Daihan Pharmaceutical Co.,Ltd. (KOSDAQ: 023910)
South Korea
· Delayed Price · Currency is KRW 26,850
0.00 (0.00%)
Dec 20, 2024, 9:00 AM KST
Daihan Pharmaceutical Co.,Ltd. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 30,665 | 28,426 | 24,961 | 22,670 | 17,381 | 28,167 | Upgrade
|
| Depreciation & Amortization | 7,635 | 8,663 | 9,208 | 11,411 | 11,300 | 10,777 | Upgrade
|
| Loss (Gain) From Sale of Assets | -56.81 | -22.53 | 9.4 | -41.28 | -19.72 | -29.98 | Upgrade
|
| Loss (Gain) From Sale of Investments | -342.34 | -288.69 | - | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | -9.41 | 10.8 | -33.29 | -142.8 | -319.09 | -330.49 | Upgrade
|
| Other Operating Activities | 4,988 | 4,194 | 2,632 | 7,386 | 8,587 | 256.08 | Upgrade
|
| Change in Accounts Receivable | 2,876 | 437.93 | -2,172 | -10.94 | 7,321 | 4,537 | Upgrade
|
| Change in Inventory | -3,648 | 1,271 | -4,407 | 2,969 | -3,812 | 878.39 | Upgrade
|
| Change in Accounts Payable | -1,646 | -877.61 | 2,997 | -389.71 | -455.66 | -4,221 | Upgrade
|
| Change in Other Net Operating Assets | -3,452 | -2,954 | -4,194 | -3,234 | -6,355 | -4,770 | Upgrade
|
| Operating Cash Flow | 37,009 | 38,860 | 28,999 | 40,617 | 33,627 | 35,264 | Upgrade
|
| Operating Cash Flow Growth | -5.49% | 34.00% | -28.60% | 20.79% | -4.64% | -21.54% | Upgrade
|
| Capital Expenditures | -21,415 | -21,280 | -8,621 | -11,850 | -5,360 | -17,305 | Upgrade
|
| Sale of Property, Plant & Equipment | 56.82 | 22.53 | - | 41.66 | 26.81 | 4,068 | Upgrade
|
| Investment in Securities | -42,293 | 3,235 | 8,635 | 283.86 | -5,595 | -7,535 | Upgrade
|
| Other Investing Activities | 10 | 25 | 180 | 10 | -9 | -6 | Upgrade
|
| Investing Cash Flow | -63,641 | -17,998 | 193.48 | -11,515 | -10,938 | -20,777 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 3,155 | Upgrade
|
| Total Debt Issued | - | - | - | - | - | 3,155 | Upgrade
|
| Short-Term Debt Repaid | - | -2,500 | -200 | -1,000 | -1,300 | -7,000 | Upgrade
|
| Long-Term Debt Repaid | - | -4,080 | -16,817 | -4,300 | -2,301 | -4,790 | Upgrade
|
| Total Debt Repaid | - | -6,580 | -17,017 | -5,300 | -3,601 | -11,790 | Upgrade
|
| Net Debt Issued (Repaid) | - | -6,580 | -17,017 | -5,300 | -3,601 | -8,634 | Upgrade
|
| Repurchase of Common Stock | - | - | -3,418 | - | - | - | Upgrade
|
| Dividends Paid | -4,329 | -3,752 | -2,108 | -2,108 | -2,108 | -1,643 | Upgrade
|
| Financing Cash Flow | -4,329 | -10,332 | -22,543 | -7,408 | -5,709 | -10,278 | Upgrade
|
| Foreign Exchange Rate Adjustments | -286.5 | 113.04 | 441.94 | 671.96 | -418.12 | 121.48 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | 0 | -0 | 0 | 0 | Upgrade
|
| Net Cash Flow | -31,248 | 10,644 | 7,092 | 22,367 | 16,562 | 4,330 | Upgrade
|
| Free Cash Flow | 15,594 | 17,580 | 20,378 | 28,767 | 28,267 | 17,959 | Upgrade
|
| Free Cash Flow Growth | -35.42% | -13.73% | -29.16% | 1.77% | 57.40% | - | Upgrade
|
| Free Cash Flow Margin | 7.72% | 8.97% | 11.06% | 16.78% | 17.02% | 10.64% | Upgrade
|
| Free Cash Flow Per Share | 2651.95 | 2989.79 | 3405.28 | 4794.06 | 4711.52 | 2992.84 | Upgrade
|
| Cash Interest Paid | - | 52.47 | 582.23 | 451.55 | 596.73 | 895.2 | Upgrade
|
| Cash Income Tax Paid | 7,932 | 8,656 | 8,869 | 3,247 | 8,022 | 8,971 | Upgrade
|
| Levered Free Cash Flow | 8,834 | 13,570 | 17,249 | 25,715 | 23,070 | 13,596 | Upgrade
|
| Unlevered Free Cash Flow | 8,834 | 13,603 | 17,620 | 26,009 | 23,456 | 14,151 | Upgrade
|
| Change in Net Working Capital | 626.42 | -3,848 | 3,571 | -8,280 | 1,211 | 345.22 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.